Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 176

1.

Investigating the Association Between Verbal Forgetting and Pathological Markers of Alzheimer's and Lewy Body Diseases.

Schaeffer MJ, Callahan BL; Alzheimer’s Disease Neuroimaging Initiative.

J Alzheimers Dis. 2019 Jul 5. doi: 10.3233/JAD-180962. [Epub ahead of print]

PMID:
31282412
2.

High-throughput amplicon sequencing of the full-length 16S rRNA gene with single-nucleotide resolution.

Callahan BJ, Wong J, Heiner C, Oh S, Theriot CM, Gulati AS, McGill SK, Dougherty MK.

Nucleic Acids Res. 2019 Jul 3. pii: gkz569. doi: 10.1093/nar/gkz569. [Epub ahead of print]

PMID:
31269198
3.

Potential MMP2-mediated availability of HLA binding, mutant ECM peptides reflects better melanoma survival rates and greater T-cell infiltrates.

Zaman S, Chobrutskiy BI, Patel JS, Callahan BM, Mihyu MM, Diviney A, Blanck G.

Lab Invest. 2019 Apr 24. doi: 10.1038/s41374-019-0248-3. [Epub ahead of print]

PMID:
31019293
4.

White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID): Knowledge gaps and opportunities.

Alber J, Alladi S, Bae HJ, Barton DA, Beckett LA, Bell JM, Berman SE, Biessels GJ, Black SE, Bos I, Bowman GL, Brai E, Brickman AM, Callahan BL, Corriveau RA, Fossati S, Gottesman RF, Gustafson DR, Hachinski V, Hayden KM, Helman AM, Hughes TM, Isaacs JD, Jefferson AL, Johnson SC, Kapasi A, Kern S, Kwon JC, Kukolja J, Lee A, Lockhart SN, Murray A, Osborn KE, Power MC, Price BR, Rhodius-Meester HFM, Rondeau JA, Rosen AC, Rosene DL, Schneider JA, Scholtzova H, Shaaban CE, Silva NCBS, Snyder HM, Swardfager W, Troen AM, van Veluw SJ, Vemuri P, Wallin A, Wellington C, Wilcock DM, Xie SX, Hainsworth AH.

Alzheimers Dement (N Y). 2019 Apr 9;5:107-117. doi: 10.1016/j.trci.2019.02.001. eCollection 2019. Review.

5.

Matrix-Metalloprotease Resistant Mucin-16 (MUC16) Peptide Mutants Represent a Worse Lung Adenocarcinoma Outcome.

Patel JS, Callahan BM, Chobrutskiy BI, Blanck G.

Proteomics Clin Appl. 2019 Feb 20:e1800155. doi: 10.1002/prca.201800155. [Epub ahead of print]

PMID:
30790454
6.

T-cell receptor V and J usage paired with specific HLA alleles associates with distinct cervical cancer survival rates.

Roca AM, Chobrutskiy BI, Callahan BM, Blanck G.

Hum Immunol. 2019 Apr;80(4):237-242. doi: 10.1016/j.humimm.2019.01.005. Epub 2019 Jan 23.

PMID:
30684568
7.

Sterol A-ring plasticity in hedgehog protein cholesterolysis supports a primitive substrate selectivity mechanism.

Ciulla DA, Wagner AG, Liu X, Cooper CL, Jorgensen MT, Wang C, Goyal P, Banavali NK, Pezzullo JL, Giner JL, Callahan BP.

Chem Commun (Camb). 2019 Feb 5;55(12):1829-1832. doi: 10.1039/c8cc09729a.

PMID:
30672911
8.

Multiomics modeling of the immunome, transcriptome, microbiome, proteome and metabolome adaptations during human pregnancy.

Ghaemi MS, DiGiulio DB, Contrepois K, Callahan B, Ngo TTM, Lee-McMullen B, Lehallier B, Robaczewska A, Mcilwain D, Rosenberg-Hasson Y, Wong RJ, Quaintance C, Culos A, Stanley N, Tanada A, Tsai A, Gaudilliere D, Ganio E, Han X, Ando K, McNeil L, Tingle M, Wise P, Maric I, Sirota M, Wyss-Coray T, Winn VD, Druzin ML, Gibbs R, Darmstadt GL, Lewis DB, Partovi Nia V, Agard B, Tibshirani R, Nolan G, Snyder MP, Relman DA, Quake SR, Shaw GM, Stevenson DK, Angst MS, Gaudilliere B, Aghaeepour N.

Bioinformatics. 2019 Jan 1;35(1):95-103. doi: 10.1093/bioinformatics/bty537.

9.

Simple statistical identification and removal of contaminant sequences in marker-gene and metagenomics data.

Davis NM, Proctor DM, Holmes SP, Relman DA, Callahan BJ.

Microbiome. 2018 Dec 17;6(1):226. doi: 10.1186/s40168-018-0605-2.

10.

TRB-J1 usage, in combination with the HLA-A*01:01 allele, represents an apparent survival advantage for uterine corpus endometrial carcinoma: Comparisons with microscopic assessments of lymphocyte infiltrates.

Clark KR, Tong WL, Callahan BM, Yavorski JM, Tu YN, Blanck G.

Int J Immunogenet. 2019 Feb;46(1):31-37. doi: 10.1111/iji.12409. Epub 2018 Nov 26.

PMID:
30474304
11.

MMP7 sensitivity of mutant ECM proteins: An indicator of melanoma survival rates and T-cell infiltration.

Zaman S, Chobrutskiy BI, Patel JS, Callahan BM, Tong WL, Mihyu MM, Blanck G.

Clin Biochem. 2019 Jan;63:85-91. doi: 10.1016/j.clinbiochem.2018.11.004. Epub 2018 Nov 8.

PMID:
30414845
12.

Examining the validity of the ADHD concept in adults and older adults.

Callahan BL, Plamondon A.

CNS Spectr. 2018 Oct 8:1-8. doi: 10.1017/S1092852918001190. [Epub ahead of print]

PMID:
30295232
13.

Dosing Regimen of Enrofloxacin Impacts Intestinal Pharmacokinetics and the Fecal Microbiota in Steers.

Ferguson KM, Jacob ME, Theriot CM, Callahan BJ, Prange T, Papich MG, Foster DM.

Front Microbiol. 2018 Sep 19;9:2190. doi: 10.3389/fmicb.2018.02190. eCollection 2018.

14.

Immune receptor recombinations from breast cancer exome files, independently and in combination with specific HLA alleles, correlate with better survival rates.

Tong WL, Callahan BM, Tu YN, Zaman S, Chobrutskiy BI, Blanck G.

Breast Cancer Res Treat. 2019 Jan;173(1):167-177. doi: 10.1007/s10549-018-4961-1. Epub 2018 Sep 18.

PMID:
30229447
15.

Mutant cytoskeletal and ECM peptides sensitive to the ST14 protease are associated with a worse outcome for glioblastoma multiforme.

Zaman S, Chobrutskiy BI, Patel JS, Callahan BM, Tong WL, Blanck G.

Biochem Biophys Res Commun. 2018 Sep 18;503(4):2218-2225. doi: 10.1016/j.bbrc.2018.06.141. Epub 2018 Jul 17.

PMID:
29953855
16.

Pollen wall degradation in the Brassicaceae permits cell emergence after pollination.

Edlund AF, Olsen K, Mendoza C, Wang J, Buckley T, Nguyen M, Callahan B, Owen HA.

Am J Bot. 2017 Aug;104(8):1266-1273. doi: 10.3732/ajb.1700201.

17.

T cell receptor-β J usage, in combination with particular HLA class II alleles, correlates with better cancer survival rates.

Callahan BM, Tong WL, Blanck G.

Immunol Res. 2018 Apr;66(2):219-223. doi: 10.1007/s12026-018-8990-y.

PMID:
29594966
18.

T-cell receptor-β V and J usage, in combination with particular HLA class I and class II alleles, correlates with cancer survival patterns.

Callahan BM, Yavorski JM, Tu YN, Tong WL, Kinskey JC, Clark KR, Fawcett TJ, Blanck G.

Cancer Immunol Immunother. 2018 Jun;67(6):885-892. doi: 10.1007/s00262-018-2139-7. Epub 2018 Mar 5.

PMID:
29508024
19.

In Nature, There Is Only Diversity.

McLaren MR, Callahan BJ.

MBio. 2018 Jan 2;9(1). pii: e02149-17. doi: 10.1128/mBio.02149-17.

20.

Cytoskeleton and ECM tumor mutant peptides: Increased protease sensitivities and potential consequences for the HLA class I mutant epitope reservoir.

Callahan BM, Patel JS, Fawcett TJ, Blanck G.

Int J Cancer. 2018 Mar 1;142(5):988-998. doi: 10.1002/ijc.31111. Epub 2017 Nov 2.

Supplemental Content

Loading ...
Support Center